The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Oxaprozin (Actirin) is a drug used for the treatment of rheumatoid arthritis, rheumatoid arthritis, osteoarthritis, ankylosis, cervical, shoulder and wrist syndrome, periarthritis of the shoulder, gout, and after trauma and surgery anti-inflammatory analgesia.
The global Oxaprozin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Oxaprozin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oxaprozin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Oxaprozin include Pfizer, Helsinn, Taisho, Ildong, PD-Rx Pharmaceuticals, Therapicon, Neolpharma, Apotex Corporation and Yichang Dongyangguang Changjiang Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oxaprozin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oxaprozin.
Report Scope
The Oxaprozin market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oxaprozin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oxaprozin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Helsinn
Taisho
Ildong
PD-Rx Pharmaceuticals
Therapicon
Neolpharma
Apotex Corporation
Yichang Dongyangguang Changjiang Pharmaceutical
Hubei Baike Hengdi Pharmaceutical
Fuan Pharmaceutical Group
Hubei Baike Hengdi Pharmaceutical
Pfizer
Segment by Type
Tablets
Capsule
Segment by Application
Rheumatoid Arthritis
Chronic Infectious Arthritis
Osteoarthritis
Ankylosing Spondylitis
Neck Shoulder Wrist Syndrome
Periarthritis Of Shoulder
Gout
Anti-Inflammatory and Analgesic Effects After Trauma and Surgery
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oxaprozin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oxaprozin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Oxaprozin (Actirin) is a drug used for the treatment of rheumatoid arthritis, rheumatoid arthritis, osteoarthritis, ankylosis, cervical, shoulder and wrist syndrome, periarthritis of the shoulder, gout, and after trauma and surgery anti-inflammatory analgesia.
The global Oxaprozin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Oxaprozin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oxaprozin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Oxaprozin include Pfizer, Helsinn, Taisho, Ildong, PD-Rx Pharmaceuticals, Therapicon, Neolpharma, Apotex Corporation and Yichang Dongyangguang Changjiang Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oxaprozin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oxaprozin.
Report Scope
The Oxaprozin market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oxaprozin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oxaprozin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Helsinn
Taisho
Ildong
PD-Rx Pharmaceuticals
Therapicon
Neolpharma
Apotex Corporation
Yichang Dongyangguang Changjiang Pharmaceutical
Hubei Baike Hengdi Pharmaceutical
Fuan Pharmaceutical Group
Hubei Baike Hengdi Pharmaceutical
Pfizer
Segment by Type
Tablets
Capsule
Segment by Application
Rheumatoid Arthritis
Chronic Infectious Arthritis
Osteoarthritis
Ankylosing Spondylitis
Neck Shoulder Wrist Syndrome
Periarthritis Of Shoulder
Gout
Anti-Inflammatory and Analgesic Effects After Trauma and Surgery
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oxaprozin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oxaprozin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Oxaprozin Market Overview
1.1 Product Overview and Scope of Oxaprozin
1.2 Oxaprozin Segment by Type
1.2.1 Global Oxaprozin Market Value Comparison by Type (2024-2030)
1.2.2 Tablets
1.2.3 Capsule
1.3 Oxaprozin Segment by Application
1.3.1 Global Oxaprozin Market Value by Application: (2024-2030)
1.3.2 Rheumatoid Arthritis
1.3.3 Chronic Infectious Arthritis
1.3.4 Osteoarthritis
1.3.5 Ankylosing Spondylitis
1.3.6 Neck Shoulder Wrist Syndrome
1.3.7 Periarthritis Of Shoulder
1.3.8 Gout
1.3.9 Anti-Inflammatory and Analgesic Effects After Trauma and Surgery
1.3.10 Other
1.4 Global Oxaprozin Market Size Estimates and Forecasts
1.4.1 Global Oxaprozin Revenue 2019-2030
1.4.2 Global Oxaprozin Sales 2019-2030
1.4.3 Global Oxaprozin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oxaprozin Market Competition by Manufacturers
2.1 Global Oxaprozin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oxaprozin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oxaprozin Average Price by Manufacturers (2019-2024)
2.4 Global Oxaprozin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oxaprozin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oxaprozin, Product Type & Application
2.7 Oxaprozin Market Competitive Situation and Trends
2.7.1 Oxaprozin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oxaprozin Players Market Share by Revenue
2.7.3 Global Oxaprozin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oxaprozin Retrospective Market Scenario by Region
3.1 Global Oxaprozin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oxaprozin Global Oxaprozin Sales by Region: 2019-2030
3.2.1 Global Oxaprozin Sales by Region: 2019-2024
3.2.2 Global Oxaprozin Sales by Region: 2025-2030
3.3 Global Oxaprozin Global Oxaprozin Revenue by Region: 2019-2030
3.3.1 Global Oxaprozin Revenue by Region: 2019-2024
3.3.2 Global Oxaprozin Revenue by Region: 2025-2030
3.4 North America Oxaprozin Market Facts & Figures by Country
3.4.1 North America Oxaprozin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oxaprozin Sales by Country (2019-2030)
3.4.3 North America Oxaprozin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Oxaprozin Market Facts & Figures by Country
3.5.1 Europe Oxaprozin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oxaprozin Sales by Country (2019-2030)
3.5.3 Europe Oxaprozin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oxaprozin Market Facts & Figures by Country
3.6.1 Asia Pacific Oxaprozin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oxaprozin Sales by Country (2019-2030)
3.6.3 Asia Pacific Oxaprozin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Oxaprozin Market Facts & Figures by Country
3.7.1 Latin America Oxaprozin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oxaprozin Sales by Country (2019-2030)
3.7.3 Latin America Oxaprozin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oxaprozin Market Facts & Figures by Country
3.8.1 Middle East and Africa Oxaprozin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oxaprozin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oxaprozin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oxaprozin Sales by Type (2019-2030)
4.1.1 Global Oxaprozin Sales by Type (2019-2024)
4.1.2 Global Oxaprozin Sales by Type (2025-2030)
4.1.3 Global Oxaprozin Sales Market Share by Type (2019-2030)
4.2 Global Oxaprozin Revenue by Type (2019-2030)
4.2.1 Global Oxaprozin Revenue by Type (2019-2024)
4.2.2 Global Oxaprozin Revenue by Type (2025-2030)
4.2.3 Global Oxaprozin Revenue Market Share by Type (2019-2030)
4.3 Global Oxaprozin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oxaprozin Sales by Application (2019-2030)
5.1.1 Global Oxaprozin Sales by Application (2019-2024)
5.1.2 Global Oxaprozin Sales by Application (2025-2030)
5.1.3 Global Oxaprozin Sales Market Share by Application (2019-2030)
5.2 Global Oxaprozin Revenue by Application (2019-2030)
5.2.1 Global Oxaprozin Revenue by Application (2019-2024)
5.2.2 Global Oxaprozin Revenue by Application (2025-2030)
5.2.3 Global Oxaprozin Revenue Market Share by Application (2019-2030)
5.3 Global Oxaprozin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Oxaprozin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Oxaprozin Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Helsinn
6.2.1 Helsinn Corporation Information
6.2.2 Helsinn Description and Business Overview
6.2.3 Helsinn Oxaprozin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Helsinn Oxaprozin Product Portfolio
6.2.5 Helsinn Recent Developments/Updates
6.3 Taisho
6.3.1 Taisho Corporation Information
6.3.2 Taisho Description and Business Overview
6.3.3 Taisho Oxaprozin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Taisho Oxaprozin Product Portfolio
6.3.5 Taisho Recent Developments/Updates
6.4 Ildong
6.4.1 Ildong Corporation Information
6.4.2 Ildong Description and Business Overview
6.4.3 Ildong Oxaprozin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ildong Oxaprozin Product Portfolio
6.4.5 Ildong Recent Developments/Updates
6.5 PD-Rx Pharmaceuticals
6.5.1 PD-Rx Pharmaceuticals Corporation Information
6.5.2 PD-Rx Pharmaceuticals Description and Business Overview
6.5.3 PD-Rx Pharmaceuticals Oxaprozin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 PD-Rx Pharmaceuticals Oxaprozin Product Portfolio
6.5.5 PD-Rx Pharmaceuticals Recent Developments/Updates
6.6 Therapicon
6.6.1 Therapicon Corporation Information
6.6.2 Therapicon Description and Business Overview
6.6.3 Therapicon Oxaprozin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Therapicon Oxaprozin Product Portfolio
6.6.5 Therapicon Recent Developments/Updates
6.7 Neolpharma
6.6.1 Neolpharma Corporation Information
6.6.2 Neolpharma Description and Business Overview
6.6.3 Neolpharma Oxaprozin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Neolpharma Oxaprozin Product Portfolio
6.7.5 Neolpharma Recent Developments/Updates
6.8 Apotex Corporation
6.8.1 Apotex Corporation Corporation Information
6.8.2 Apotex Corporation Description and Business Overview
6.8.3 Apotex Corporation Oxaprozin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Apotex Corporation Oxaprozin Product Portfolio
6.8.5 Apotex Corporation Recent Developments/Updates
6.9 Yichang Dongyangguang Changjiang Pharmaceutical
6.9.1 Yichang Dongyangguang Changjiang Pharmaceutical Corporation Information
6.9.2 Yichang Dongyangguang Changjiang Pharmaceutical Description and Business Overview
6.9.3 Yichang Dongyangguang Changjiang Pharmaceutical Oxaprozin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Yichang Dongyangguang Changjiang Pharmaceutical Oxaprozin Product Portfolio
6.9.5 Yichang Dongyangguang Changjiang Pharmaceutical Recent Developments/Updates
6.10 Hubei Baike Hengdi Pharmaceutical
6.10.1 Hubei Baike Hengdi Pharmaceutical Corporation Information
6.10.2 Hubei Baike Hengdi Pharmaceutical Description and Business Overview
6.10.3 Hubei Baike Hengdi Pharmaceutical Oxaprozin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hubei Baike Hengdi Pharmaceutical Oxaprozin Product Portfolio
6.10.5 Hubei Baike Hengdi Pharmaceutical Recent Developments/Updates
6.11 Fuan Pharmaceutical Group
6.11.1 Fuan Pharmaceutical Group Corporation Information
6.11.2 Fuan Pharmaceutical Group Oxaprozin Description and Business Overview
6.11.3 Fuan Pharmaceutical Group Oxaprozin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Fuan Pharmaceutical Group Oxaprozin Product Portfolio
6.11.5 Fuan Pharmaceutical Group Recent Developments/Updates
6.12 Hubei Baike Hengdi Pharmaceutical
6.12.1 Hubei Baike Hengdi Pharmaceutical Corporation Information
6.12.2 Hubei Baike Hengdi Pharmaceutical Oxaprozin Description and Business Overview
6.12.3 Hubei Baike Hengdi Pharmaceutical Oxaprozin Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Hubei Baike Hengdi Pharmaceutical Oxaprozin Product Portfolio
6.12.5 Hubei Baike Hengdi Pharmaceutical Recent Developments/Updates
6.31 Pfizer
6.31.1 Pfizer Corporation Information
6.31.2 Pfizer Oxaprozin Description and Business Overview
6.31.3 Pfizer Oxaprozin Sales, Revenue and Gross Margin (2019-2024)
6.31.4 Pfizer Oxaprozin Product Portfolio
6.31.5 Pfizer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oxaprozin Industry Chain Analysis
7.2 Oxaprozin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oxaprozin Production Mode & Process
7.4 Oxaprozin Sales and Marketing
7.4.1 Oxaprozin Sales Channels
7.4.2 Oxaprozin Distributors
7.5 Oxaprozin Customers
8 Oxaprozin Market Dynamics
8.1 Oxaprozin Industry Trends
8.2 Oxaprozin Market Drivers
8.3 Oxaprozin Market Challenges
8.4 Oxaprozin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Oxaprozin Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Oxaprozin Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Oxaprozin Market Competitive Situation by Manufacturers in 2023
Table 4. Global Oxaprozin Sales (KG) of Key Manufacturers (2019-2024)
Table 5. Global Oxaprozin Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Oxaprozin Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Oxaprozin Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Oxaprozin Average Price (US$/G) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Oxaprozin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Oxaprozin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oxaprozin, Product Type & Application
Table 12. Global Key Manufacturers of Oxaprozin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oxaprozin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxaprozin as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oxaprozin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Oxaprozin Sales by Region (2019-2024) & (KG)
Table 18. Global Oxaprozin Sales Market Share by Region (2019-2024)
Table 19. Global Oxaprozin Sales by Region (2025-2030) & (KG)
Table 20. Global Oxaprozin Sales Market Share by Region (2025-2030)
Table 21. Global Oxaprozin Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Oxaprozin Revenue Market Share by Region (2019-2024)
Table 23. Global Oxaprozin Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Oxaprozin Revenue Market Share by Region (2025-2030)
Table 25. North America Oxaprozin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Oxaprozin Sales by Country (2019-2024) & (KG)
Table 27. North America Oxaprozin Sales by Country (2025-2030) & (KG)
Table 28. North America Oxaprozin Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Oxaprozin Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Oxaprozin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Oxaprozin Sales by Country (2019-2024) & (KG)
Table 32. Europe Oxaprozin Sales by Country (2025-2030) & (KG)
Table 33. Europe Oxaprozin Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Oxaprozin Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Oxaprozin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Oxaprozin Sales by Region (2019-2024) & (KG)
Table 37. Asia Pacific Oxaprozin Sales by Region (2025-2030) & (KG)
Table 38. Asia Pacific Oxaprozin Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Oxaprozin Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Oxaprozin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Oxaprozin Sales by Country (2019-2024) & (KG)
Table 42. Latin America Oxaprozin Sales by Country (2025-2030) & (KG)
Table 43. Latin America Oxaprozin Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Oxaprozin Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Oxaprozin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Oxaprozin Sales by Country (2019-2024) & (KG)
Table 47. Middle East & Africa Oxaprozin Sales by Country (2025-2030) & (KG)
Table 48. Middle East & Africa Oxaprozin Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Oxaprozin Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Oxaprozin Sales (KG) by Type (2019-2024)
Table 51. Global Oxaprozin Sales (KG) by Type (2025-2030)
Table 52. Global Oxaprozin Sales Market Share by Type (2019-2024)
Table 53. Global Oxaprozin Sales Market Share by Type (2025-2030)
Table 54. Global Oxaprozin Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Oxaprozin Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Oxaprozin Revenue Market Share by Type (2019-2024)
Table 57. Global Oxaprozin Revenue Market Share by Type (2025-2030)
Table 58. Global Oxaprozin Price (US$/G) by Type (2019-2024)
Table 59. Global Oxaprozin Price (US$/G) by Type (2025-2030)
Table 60. Global Oxaprozin Sales (KG) by Application (2019-2024)
Table 61. Global Oxaprozin Sales (KG) by Application (2025-2030)
Table 62. Global Oxaprozin Sales Market Share by Application (2019-2024)
Table 63. Global Oxaprozin Sales Market Share by Application (2025-2030)
Table 64. Global Oxaprozin Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Oxaprozin Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Oxaprozin Revenue Market Share by Application (2019-2024)
Table 67. Global Oxaprozin Revenue Market Share by Application (2025-2030)
Table 68. Global Oxaprozin Price (US$/G) by Application (2019-2024)
Table 69. Global Oxaprozin Price (US$/G) by Application (2025-2030)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 73. Pfizer Oxaprozin Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Helsinn Corporation Information
Table 76. Helsinn Description and Business Overview
Table 77. Helsinn Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 78. Helsinn Oxaprozin Product
Table 79. Helsinn Recent Developments/Updates
Table 80. Taisho Corporation Information
Table 81. Taisho Description and Business Overview
Table 82. Taisho Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 83. Taisho Oxaprozin Product
Table 84. Taisho Recent Developments/Updates
Table 85. Ildong Corporation Information
Table 86. Ildong Description and Business Overview
Table 87. Ildong Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 88. Ildong Oxaprozin Product
Table 89. Ildong Recent Developments/Updates
Table 90. PD-Rx Pharmaceuticals Corporation Information
Table 91. PD-Rx Pharmaceuticals Description and Business Overview
Table 92. PD-Rx Pharmaceuticals Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 93. PD-Rx Pharmaceuticals Oxaprozin Product
Table 94. PD-Rx Pharmaceuticals Recent Developments/Updates
Table 95. Therapicon Corporation Information
Table 96. Therapicon Description and Business Overview
Table 97. Therapicon Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 98. Therapicon Oxaprozin Product
Table 99. Therapicon Recent Developments/Updates
Table 100. Neolpharma Corporation Information
Table 101. Neolpharma Description and Business Overview
Table 102. Neolpharma Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 103. Neolpharma Oxaprozin Product
Table 104. Neolpharma Recent Developments/Updates
Table 105. Apotex Corporation Corporation Information
Table 106. Apotex Corporation Description and Business Overview
Table 107. Apotex Corporation Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 108. Apotex Corporation Oxaprozin Product
Table 109. Apotex Corporation Recent Developments/Updates
Table 110. Yichang Dongyangguang Changjiang Pharmaceutical Corporation Information
Table 111. Yichang Dongyangguang Changjiang Pharmaceutical Description and Business Overview
Table 112. Yichang Dongyangguang Changjiang Pharmaceutical Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 113. Yichang Dongyangguang Changjiang Pharmaceutical Oxaprozin Product
Table 114. Yichang Dongyangguang Changjiang Pharmaceutical Recent Developments/Updates
Table 115. Hubei Baike Hengdi Pharmaceutical Corporation Information
Table 116. Hubei Baike Hengdi Pharmaceutical Description and Business Overview
Table 117. Hubei Baike Hengdi Pharmaceutical Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 118. Hubei Baike Hengdi Pharmaceutical Oxaprozin Product
Table 119. Hubei Baike Hengdi Pharmaceutical Recent Developments/Updates
Table 120. Fuan Pharmaceutical Group Corporation Information
Table 121. Fuan Pharmaceutical Group Description and Business Overview
Table 122. Fuan Pharmaceutical Group Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 123. Fuan Pharmaceutical Group Oxaprozin Product
Table 124. Fuan Pharmaceutical Group Recent Developments/Updates
Table 125. Hubei Baike Hengdi Pharmaceutical Corporation Information
Table 126. Hubei Baike Hengdi Pharmaceutical Description and Business Overview
Table 127. Hubei Baike Hengdi Pharmaceutical Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 128. Hubei Baike Hengdi Pharmaceutical Oxaprozin Product
Table 129. Hubei Baike Hengdi Pharmaceutical Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Oxaprozin Distributors List
Table 133. Oxaprozin Customers List
Table 134. Oxaprozin Market Trends
Table 135. Oxaprozin Market Drivers
Table 136. Oxaprozin Market Challenges
Table 137. Oxaprozin Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oxaprozin
Figure 2. Global Oxaprozin Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Oxaprozin Market Share by Type in 2023 & 2030
Figure 4. Tablets Product Picture
Figure 5. Capsule Product Picture
Figure 6. Global Oxaprozin Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Oxaprozin Market Share by Application in 2023 & 2030
Figure 8. Rheumatoid Arthritis
Figure 9. Chronic Infectious Arthritis
Figure 10. Osteoarthritis
Figure 11. Ankylosing Spondylitis
Figure 12. Neck Shoulder Wrist Syndrome
Figure 13. Periarthritis Of Shoulder
Figure 14. Gout
Figure 15. Anti-Inflammatory and Analgesic Effects After Trauma and Surgery
Figure 16. Other
Figure 17. Global Oxaprozin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Oxaprozin Market Size (2019-2030) & (US$ Million)
Figure 19. Global Oxaprozin Sales (2019-2030) & (KG)
Figure 20. Global Oxaprozin Average Price (US$/G) & (2019-2030)
Figure 21. Oxaprozin Report Years Considered
Figure 22. Oxaprozin Sales Share by Manufacturers in 2023
Figure 23. Global Oxaprozin Revenue Share by Manufacturers in 2023
Figure 24. The Global 5 and 10 Largest Oxaprozin Players: Market Share by Revenue in 2023
Figure 25. Oxaprozin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 26. Global Oxaprozin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 27. North America Oxaprozin Sales Market Share by Country (2019-2030)
Figure 28. North America Oxaprozin Revenue Market Share by Country (2019-2030)
Figure 29. U.S. Oxaprozin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Canada Oxaprozin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Europe Oxaprozin Sales Market Share by Country (2019-2030)
Figure 32. Europe Oxaprozin Revenue Market Share by Country (2019-2030)
Figure 33. Germany Oxaprozin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. France Oxaprozin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. U.K. Oxaprozin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Italy Oxaprozin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Russia Oxaprozin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Asia Pacific Oxaprozin Sales Market Share by Region (2019-2030)
Figure 39. Asia Pacific Oxaprozin Revenue Market Share by Region (2019-2030)
Figure 40. China Oxaprozin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Japan Oxaprozin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. South Korea Oxaprozin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. India Oxaprozin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Australia Oxaprozin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Taiwan Oxaprozin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Indonesia Oxaprozin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Thailand Oxaprozin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Malaysia Oxaprozin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Philippines Oxaprozin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Latin America Oxaprozin Sales Market Share by Country (2019-2030)
Figure 51. Latin America Oxaprozin Revenue Market Share by Country (2019-2030)
Figure 52. Mexico Oxaprozin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Brazil Oxaprozin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Argentina Oxaprozin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Middle East & Africa Oxaprozin Sales Market Share by Country (2019-2030)
Figure 56. Middle East & Africa Oxaprozin Revenue Market Share by Country (2019-2030)
Figure 57. Turkey Oxaprozin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. Saudi Arabia Oxaprozin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 59. UAE Oxaprozin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 60. Global Sales Market Share of Oxaprozin by Type (2019-2030)
Figure 61. Global Revenue Market Share of Oxaprozin by Type (2019-2030)
Figure 62. Global Oxaprozin Price (US$/G) by Type (2019-2030)
Figure 63. Global Sales Market Share of Oxaprozin by Application (2019-2030)
Figure 64. Global Revenue Market Share of Oxaprozin by Application (2019-2030)
Figure 65. Global Oxaprozin Price (US$/G) by Application (2019-2030)
Figure 66. Oxaprozin Value Chain
Figure 67. Oxaprozin Production Process
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Distributors Profiles
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
